Drugging the undruggable: Development of novel technologies to selectively regulate the expression of targets driving cancer and other diseases

Blancafort, Pilar (Investigator 01)

School of Human Sciences

Status	Finished
Effective start/end date	1/01/13 → 31/12/18

Funding

ARC Australian Research Council : A$755,320.00

Access Project

http://purl.org/au-research/grants/arc/FT130101767

10 Article
3 Review article

Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma
Sgro, A., Cursons, J., Waryah, C., Woodward, E. A., Foroutan, M., Lyu, R., Yeoh, G. C. T., Leedman, P. J. & Blancafort, P., Dec 2023, In: Clinical Epigenetics. 15, 1, 24 p., 73.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Citations (Scopus)
Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
Waryah, C., Cursons, J., Foroutan, M., Pflueger, C., Wang, E., Molania, R., Woodward, E., Sorolla, A., Wallis, C., Moses, C., Glas, I., Magalhães, L., Thompson, E. W., Fearnley, L. G., Chaffer, C. L., Davis, M., Papenfuss, A. T., Redfern, A., Lister, R. & Esteller, M. & 1 others, Blancafort, P., 4 Aug 2023, In: Advanced Science. 10, 22, 2301802.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Citations (Scopus)
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs
Waryah, C., Alves, E., Mazzieri, R., Dolcetti, R., Thompson, E. W., Redfern, A. & Blancafort, P., Jun 2023, In: Cancers. 15, 12, 3152.
Research output: Contribution to journal › Review article › peer-review

Open Access
2 Citations (Scopus)